Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04022226 · ClinicalTrials.gov registry record · Early Phase 1
EEG Characteristics in ECT
A Early Phase 1 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT04022226 is a Early Phase 1 study that has completed, run by University of New Mexico. The registered enrollment target is 11 participants.
The verdict
NCT04022226, a Early Phase 1 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.
Interventions
- DRUG Ketamine
- DRUG Methohexital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2020-10-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04022226
The ClinicalTrials.gov registry entry for NCT04022226 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT04022226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04022226 about?
NCT04022226 is a clinical study titled "EEG Characteristics in ECT". The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.
What is the current status of trial NCT04022226?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2019-10-01. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT04022226?
The interventions under investigation include: Ketamine (DRUG), Methohexital (DRUG).
Who is sponsoring clinical trial NCT04022226?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.